Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
SHSE:601607
Shanghai Pharmaceuticals Holding
|
18.61 | 51,43% | 74,37% | 60.286,59 | 2,18% | 0,63% |
|
SZSE:000999
China Resources Sanjiu Medical
& Pharmaceutical |
63.88 | 28,29% | 45,35% | 60.160,64 | 2,37% | 14,37% |
|
SHSE:600196
Shanghai Fosun Pharmaceutical (Group)
|
23.69 | 90,1% | 181,68% | 58.251,4 | 1,13% | -2,01% |
|
SEHK:874
Guangzhou Baiyunshan Pharmaceutical
Holdings Company |
23.05 | 66,89% | 0% | 53.844,3 | 3,51% | 5,05% |
|
SHSE:600079
Humanwell Healthcare (Group)
|
20.39 | 7,17% | 26,49% | 33.688,73 | 2,24% | 33,1% |
|
SZSE:000513
Livzon Pharmaceutical Group
|
36.98 | 0% | 0% | 28.754,16 | 4,49% | 6,03% |
|
SHSE:600812
North China Pharmaceutical Company.Ltd
|
5.19 | 0% | 0% | 8.887,48 | 0,19% | 0% |
|
SHSE:600664
Harbin Pharmaceutical Group
|
2.80 | 0% | 0% | 7.293,2 | 0% | 0% |
